The explanation of the disparity in RhoGDI2′s participation in different cancers remains unclear; however, the dual role of RhoGDI in controlling the activity of Rho GTPase during cancer progression may be one of the plausible reasons. The gene discussed is ARHGDIB; the disease is cancer.